Original language | English (US) |
---|---|
Pages (from-to) | 2132-2134 |
Number of pages | 3 |
Journal | JAMA - Journal of the American Medical Association |
Volume | 322 |
Issue number | 21 |
DOIs | |
State | Published - Dec 3 2019 |
Bibliographical note
Funding Information:Funding/Support: Research reported in this publication was supported by the National Cancer Institute and the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP) under award U54CA180905 (Dr Leventhal), the National Institute on Drug Abuse (NIDA) under award K24048160 (Dr Leventhal), and the NIDA and FDA CTP under award 3R01DA001411-44S1 (Dr Miech).
Funding Information:
Research reported in this publication was supported by the National Cancer Institute and the US Food and Drug Administration (FDA) Center for Tobacco Products (CTP) under award U54CA180905 (Dr Leventhal), the National Institute on Drug Abuse (NIDA) under award K24048160 (Dr Leventhal), and the NIDA and FDA CTP under award 3R01DA001411-44S1 (Dr Miech).